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Abstract  
Tissue residency is considered a defining feature of the innate lymphoid cell (ILC) 
populations located within mucosal and adipose tissues. ILCs are also present within all 
lymphoid tissues, but whether ILCs migrate between lymphoid and non-lymphoid sites and in 
what context is poorly understood. To determine whether migratory ILCs exist within 
peripheral lymph nodes (LNs), all cells within the brachial LN (bLN) of transgenic mice 
expressing a photoconvertible fluorescent protein were labelled by direct exposure to light. 
Tracking of cellular changes in the labelled LN revealed the gradual migration of new ILCs 
into the tissue, balanced by egress of ILCs dependent upon sphingosine-1-phosphate 
receptors. Most of the migratory ILCs were ILC1s, entering LNs directly from the circulation 
in a CD62L and CCR7-dependent manner and thus behaving like conventional (c)NK cells. 
Upon egress, both ILC1s and cNK cells were found to recirculate through peripheral LNs. A 
distinct population of migratory ILC2s were detected in the LN, but the majority of ILC3s 
were tissue resident. Functionally, both migratory and resident ILC1s within LNs were able 
to rapidly produce IFN-γ to support the generation of robust Th1 T cell responses after 
immunization. Thus, migratory and resident ILC populations exist within peripheral LNs, 
with ILC1s, akin to cNK cells, able to traffic into these tissues where they can contribute to 
the initiation of adaptive immunity. 
  
Introduction 
ILCs have been identified in most tissues in the body where they act as sentinels, 
orchestrating homeostasis, but able to dynamically respond to a wide range of signals 
indicative of infection or danger (1-3). As ILC populations were discovered, it became 
evident that these cells were most numerous at barrier tissues such as the gastrointestinal tract 
and lung and the majority of studies have focused on their roles at these sites (4-8). To 
address whether ILCs were tissue resident, several studies have used parabiosis models which 
indicate that the vast majority of ILCs at these barrier sites, as well as in adipose tissue, 
permanently reside within these tissues and do not traffic between host mice when the 
circulatory system is shared (9, 10), (11, 12). Current models of ILC development propose the 
seeding of tissues with progenitors that develop from both fetal liver and bone marrow and 
then expand to provide tissue resident populations (13-17). 
Although less numerous than at mucosal sites, ILCs are also present within all 
lymphoid tissues, suggesting roles influencing the adaptive immune responses initiated in 
these structures (18, 19). Crucially, how ILC populations within lymphoid tissue relate to 
those within barrier tissues is poorly understood. Analysis of the mesenteric LN (mLN) and 
spleen of parabiotic mice also suggested that most ILCs within these secondary lymphoid 
tissues were tissue resident (9). Furthermore, given the role of the lymphoid tissue inducer 
subset of ILC3s in LN and Peyer’s patch organogenesis (20), it is possible that such LN 
resident populations may be established very early in life. To date, the lack of mouse models 
that specifically and completely delete ILC populations has hindered our ability to clearly 
define their functions within lymphoid tissues (21). Beyond their ability to rapidly produce 
effector cytokines, investigations of how ILCs might regulate adaptive immune responses 
have identified that both ILC2s (22) and ILC3s (19, 23) are able to process and present 
peptides via MHCII and modulate CD4 T cell responses. Where and how ILCs might acquire 
such antigen is unresolved, but relevant to understanding the role such antigen presentation 
plays within the immune system. It is conceivable that as a consequence of antigen uptake, 
ILCs migrate from tissue to draining LNs via the lymphatics. Such trafficking would not be 
evident within the parabiosis studies used to identify tissue residency. In support of ILC 
migration from tissues to their draining LNs, direct trafficking of ILCs from the intestine to 
the mLN has been described (18) and analysis of the mLNs of mixed bone marrow chimeras 
using WT and CCR7-/- donors, indicated a cell-intrinsic requirement for CCR7 in establishing 
normal ILC populations within LNs (18). Since many studies of human ILCs rely on isolating 
these cells from blood, this suggests that circulatory ILCs exist in human blood at least, 
however, recent data indicate that the human ILCs isolated from blood include progenitor 
populations (16, 24, 25). In addition, with better understanding of ILC subsets, a highly 
migratory ILC2 population was recently described (26) suggesting that the tissue resident 
description of ILCs may not be true of all subsets in all circumstances.  Finally, cNK cells 
which share many similarities with ILC1s, are thought to be highly migratory, entering LNs 
directly from the circulation via high endothelial venules (HEV) (27). Thus, the dogma of 
ILC tissue residency needs to be further tested for lymphoid ILC populations. As we seek to 
better understand the roles ILCs play in secondary lymphoid tissue, how and when ILCs 
establish residency within LNs will help to clarify their functions the generation and 
regulation of adaptive immunity. 
To test the hypothesis that ILCs in peripheral LNs are migratory, we have used Kaede 
photoconvertible mice (28), having established methods to label all cells within a peripheral 
LN by illumination following surgical exposure (29). This approach offers direct in vivo 
assessment of the migration of new cells into the tissue, identification of resident populations 
and tracking of cells leaving the LN to new locations. Our data reveal that LNs contain both 
migratory and resident ILC populations, with the ILC1 subset highly migratory and able to 
recirculate through peripheral lymphoid tissue, where it can contribute to supporting the 
priming of CD4+ T cells after immunization.  
Results 
ILCs migrate into peripheral LNs  
To test the hypothesis that migratory ILCs exist in peripheral LNs, the bLN of Kaede 
mice was exposed through a small incision in the skin and photoconverted as described 
previously, changing the cellular fluorescence from Kaede Green to Kaede Red (29). While 
cells expressing the Kaede Red form of the fluorochrome frequently also express the Kaede 
Green form (due to a combination of incomplete conversion of total Kaede protein within the 
cell and the generation of new protein post-photoconversion), to simplify the description of 
the data, here these cells are termed ‘Kaede Red+’. Analysis of Kaede expression confirmed 
that the entire hematopoietic compartment of the LN was converted to Kaede Red+ cells (Fig. 
S1). Thus, analysis of the labelled bLN at subsequent time points after photoconversion 
allows identification of cells newly entering the tissue from unexposed sites (Kaede Green+) 
and those that have remained within the LN (Kaede Red+). A fraction of cells identified as 
Kaede Red+ resident cells may be migratory cells that have recirculated back to the initially 
photoconverted LN. This experimental approach enables the simple but direct assessment of 
residency within the LN for any cell type. After 72 hrs, approximately 95% of the CD45+ 
cells in the labelled LN were Kaede Green+ cells (Fig. 1A, B), consistent with the constant 
circulation of naïve lymphocytes through secondary lymphoid tissue. The majority of the 
Kaede Green+ cells within LNs were αβ T cells although some γδ T cells were also detected 
(Fig. 1C, D). Notably, a small but distinct population of IL-7Rα+Lin (B220, CD11b, CD11c, 
CD3, CD5, CD19, Ter119, Gr1, CD49b, F4/80 and Fc𝜀𝜀RI)- ILCs was evident and 
comparable in frequency to Langerhans cells (LCs, Fig. 1C, D). These data indicate that some 
ILCs had entered the tissue subsequent to photoconversion of the LN 72 hrs previously. 
Amongst the Kaede Red+ cells that had remained within the LN since labelling, ILCs were 
also detected and appeared enriched compared with the proportion of ILCs amongst the 
Kaede Green+ population (Fig. 1E, F). Thus, our initial analysis suggested the presence of 
both migratory and resident ILC populations within peripheral LNs.  
Whilst the majority of CD45+ population in LNs are naïve lymphocytes and thus 
expected to be highly migratory, the CD45- stromal compartment would be expected to be 
obligatorily tissue-resident. Therefore we assessed Kaede expression in LN stromal cells to 
further confirm that our experimental model properly distinguished between resident and 
migratory populations. Blood endothelial cells, fibroblastic reticular cells and lymphatic 
endothelial cells were all found to remain >96% Kaede Red+ at 72 hrs post photoconversion 
(Fig. S1) consistent with being resident populations.  
 To specifically assess the relative migratory abilities of individual cell types, 
different immune cell populations were first identified, and then Kaede Green versus Kaede 
Red expression was analysed. These data showed that for αβ and γδ T cells, the vast majority 
(>93%) had trafficked into the LN within the preceding 72 hrs (Fig. 1G). Surprisingly, 
analysis of the ILC compartment revealed that approximately half the population had newly 
arrived into the tissue within the 72 hr time frame, arguing that a substantial proportion of 
ILCs in the LN were not tissue-resident (Fig. 1G). To better understand the kinetics of ILC 
trafficking into LNs, T cell and ILC populations were assessed at different times post 
photoconversion (Fig. S2). Whilst over 90% of the LN T cell compartment were Kaede 
Green+ 24 hrs after photoconversion, only 20% of the ILCs were Kaede Green+, suggesting 
that the rate of replacement of LN ILCs within peripheral LNs with newly migrating cells, 
was substantially slower than for naïve T cells. Given the importance of CCR7 in the 
recruitment of cells into LNs, either via the lymphatics or from the blood (30), the bLN of 
CCR7-/- Kaede mice was assessed at 72 hrs post-photoconversion (Fig. 1H). For both T cells 
and ILCs, the proportion of Kaede Red+ cells increased compared to WT Kaede controls, 
however this reflected the significantly reduced cellularity of the CCR7-/- tissue due to the 
inability of cells to enter and exit many tissues in the body (Fig. 1I). Nonetheless, consistent 
with a requirement for CCR7 for T cell and ILC entry into LNs, the number of Kaede Green+ 
T cells or ILCs was substantially reduced (Fig. 1J).  
Combined, these data reveal that both migratory and resident ILC populations exist 
within peripheral LNs and the entry of migratory ILCs into these tissues is CCR7-dependent.   
 
ILCs egress from LNs in an S1P-dependent manner  
Since labelling of the LN was performed following a small excision in the skin, it was 
possible that the Kaede Green+ ILCs observed in the LN reflected additional migration of 
ILCs in response to local tissue damage, rather than normal homeostatic trafficking of these 
cells into the tissue. Enumeration of the number of Kaede Green+ versus Kaede Red+ ILCs in 
control mice (no photoconversion) compared with 72 hrs post-photoconversion indicated that 
the total number of ILCs in the LN was not increased by the process of labelling (Fig. 2A, B), 
suggesting new cells had not migrated into the tissue. Furthermore, quantitation of ILC 
numbers in the bLN of WT mice that had never undergone surgery versus those that had 
experienced a skin incision and photoconversion 72 hrs previously, revealed no differences in 
ILC numbers (Fig. S3).   
These data indicate that ILC migration into the tissue was matched by the loss of ILCs 
either through cell death or egress from the LN. The egress of B and T cells from LNs is 
dependent upon the sensing of sphingosine-1-phosphate (S1P) by S1P receptor 1 (S1P1) (31), 
whilst the egress of cNK cells from LNs is dependent upon S1P receptor 5 (S1P5) (32, 33). 
Expression of S1P1 was detected on a proportion of ILC1s, ILC2s and ILC3s isolated from the 
bLN (Fig. S4), suggesting that ILCs might use S1P:S1P1 interactions to mediate egress from 
peripheral LNs, as described for T cells. To test whether ILC egress from LNs, photoconversion 
of the bLN was performed on mice maintained on vehicle control (H2O) or the S1P receptor 
agonist FTY720, a small molecule inhibitor that blocks lymphocyte recirculation through 
inhibiting three of the five S1P receptors: S1P1, S1P3 and S1P4 (31, 34). The total number of T 
cells within the LN was not significantly altered by FTY720 treatment (Fig. S5), however, 
analysis of Kaede Red expression confirmed this was due to the expected retention of T cells 
within the LNs (Fig. S5), which in turn meant that far fewer Kaede Green+ T cells were 
migrating into the tissue (Fig. S5). Analysis of ILCs revealed an increase in the proportion of 
Kaede Red+ ILCs (Fig. 2C, D) and a significant increase in the total number of Kaede Red+ 
ILCs in the LN whilst the number of Kaede Green+ ILCs remained unchanged through FTY720 
treatment (Fig. 2E). Thus, inhibition of S1P receptor-mediated exit from the tissue resulted in 
the accumulation of ILCs within the LN, arguing that under normal conditions, these cells 
egress from the tissue. To further investigate expression of S1P receptors by ILCs, gene 
expression analysis was performed on sorted ILC1 (NK1.1+NKp46+) and non-ILC1 (NK1.1-
NKp46-) ILC populations isolated from peripheral LNs by FACS. S1P1 and S1P4, both of which 
are inhibited by FTY720, were observed to be most highly expressed by LN ILC populations, 
while relatively little expression of S1P5 was detected (Fig. S6). Interestingly, the sorted ILC1 
population, which expressed significantly higher levels of IFNγ and T-bet than the other LN 
ILC, also expressed significantly higher levels of CD62L, required for entry into LNs from 
HEV (Fig. S6).  
  Since ILCs that have left the photoconverted LN can be identified as Kaede Red+, the 
ability of ILCs to recirculate through peripheral LNs was tested by assessing Kaede Red+ 
ILCs in a pool of contralateral LNs. ILCs were enriched (through depletion of B and T cells) 
to aid identification of rare Kaede Red+ ILCs and this approach could detect a small Kaede 
Red+ ILC population that constituted only a very small proportion of the ILCs isolated from 
the contralateral LNs (0-0.7% of the population, Fig. 2F, G) although this was more than 
detected in the contralateral LNs of CCR7-/- Kaede mice. This low frequency of recirculating 
ILCs may represent either the limitations of tracking rare populations, alongside some ILCs 
migrating to tissues other than LNs. T cells recirculating from the photoconverted LN 
comprised approximately 2.5% of the T cell population in contralateral LNs (Fig. 2H and Fig. 
S5). To further assess expression of molecules associated with retention of cells within 
tissues, expression of CD69 was assessed on Kaede Green+ and Kaede Red+ ILCs. Notably, 
Kaede Green+ ILCs expressed very little CD69, whilst the majority of Kaede Red+ ILCs were 
CD69+, consistent with a tissue resident phenotype (Fig. 2I, J).  
In summary, these data show that the migration of ILCs into peripheral LNs is 
accompanied by the egress of these cells in an S1P receptor-dependent manner and at least 
some of these ILCs then recirculate through other peripheral LNs. 
 
ILC1s are the migratory ILC subset 
To determine whether all ILC populations were equally migratory we sought to define 
the Kaede Green+ and Kaede Red+ ILCs within the bLN. ILC subsets in the bLN can be 
readily distinguished by staining for transcription factors (TFs) (Fig. S7) (18). Importantly, T-
bet+ ILC1s in the bLN lacked expression of Eomes (i.e. T-bet+Eomes-) demonstrating that the 
ILC1s we had identified, were not misidentified cNK cells (Fig. S7). In photoconverted LNs, 
methods to preserve Kaede protein expression resulted in suboptimal TF detection. 
Therefore, a panel of surface markers that identified the ILC subsets in the bLN of WT mice 
was devised (Fig. S7) and used to identify different ILC subsets only by surface markers (Fig. 
3A, B). Analysis of Kaede Green versus Kaede Red protein expression in bLN ILCs at 72 hrs 
post-photoconversion revealed that there were relatively few migratory ILC2s and ILC3s 
(~20% Kaede Green+), whilst ILC1s were much more migratory since over 60% were Kaede 
Green+ (Fig. 3C). Similar proportions of Kaede Green+ ILCs were also observed at 1 wk post 
photoconversion (Fig. 3D), indicating that that LNs contained both migratory and resident 
ILC populations, with different subsets showing distinct migratory properties (Fig. 3E). ILC 
tissue residency within the LN was then further assessed using a second photoconvertible 
mouse strain, the H2B-Dendra2 model (35). The fusion of the Dendra protein to histones 
enabled intracellular staining of TFs to be used to more definitively identify ILC subsets. In 
H2B-Dendra2 mice, ILC subsets could be split into resident and migratory populations in a 
comparable manner to that observed in the Kaede mice (Fig. S8). Notably, identification of 
ILC2s based upon GATA-3 expression, rather than surface markers used in Kaede mice, 
indicated a larger migratory ILC2 population within the LN (Fig. S9). Since expression of 
Kaede Red protein is lost over several days in rapidly proliferating cells due to label dilution, 
the emergence of Kaede Green+ ILCs could theoretically be explained by highly proliferative 
populations in the tissue (28). Analysis of Ki-67 expression within the bLN revealed that the 
majority of each ILC subset was Ki-67- and the proportions of Ki-67+ ILC1s and ILC2s were 
comparable, despite very different patterns of Kaede Red and Kaede Green expression at 72 
hrs post photoconversion (Fig. S10). Thus the high proportion of Kaede Green+ ILC1s cannot 
be explained by Kaede red protein dilution through proliferation. 
The IL-7Rα+T-bet+Eomes- ILC1s assessed within the LN are developmentally distinct 
from cNK cells, despite both being grouped in the ILC1 subset and cNK cells having been 
previously shown to enter LNs direct from the circulation (27). To directly compare ILC1 
and cNK cell migration, these two populations were identified within the photoconverted 
bLN at 72 hrs post labelling and in a pool of contralateral LNs (Fig. S11). Notably, while 
ILC1s were 60% Kaede Green+, cNK cells were 90% Kaede Green+, indicating that while the 
LN compartment of ILC1s contains both migratory and resident populations, the vast 
majority of cNK cells are highly migratory. Analysis of contralateral LNs identified a small 
Kaede Red+ ILC1 population and a larger Kaede Red+ cNK cell population, demonstrating 
that both populations recirculate through peripheral LNs.  
Given that cNK cells are reported to enter LNs via HEV (27), ILC populations in 
mouse blood were assessed to investigate whether ILC1s in the murine circulation might be 
the source of the ILCs trafficking into the bLN. A very small (<0.05 – 0.011 % total CD45+ 
cells) IL-7Rα+Lin- population was detected in the circulation, the majority of which expressed 
both NK1.1 and NKp46 at steady state alongside a few putative ILC2s (NK1.1-KLRG-1+) 
(Fig. 3F, G). These ILCs also expressed T-bet (Fig. 3H) providing further evidence of an 
ILC1 phenotype and consistent with previous data suggesting ILC1s were present in the 
circulation (9, 11). To investigate whether ILC1s in the blood were equipped to enter LNs 
directly from the circulation via HEV, expression of CD62L and CCR7 were assessed. 
Notably, approximately half of blood ILC1s expressed both CD62L and CCR7, whereas the 
few other ILCs (IL-7Rα+Lin- cells) detectable in blood appeared to lack expression of these 
molecules (Fig. 3I). Combined, our analysis of ILC subsets revealed that ILC1s show 
behavioral similarities to cNK cells and a circulating ILC1 population in the blood is able to 
traffic into and out of peripheral LNs.  
 
ILCs do not migrate from the skin to peripheral LNs under steady state conditions 
Whilst our data was consistent with ILC migration into LNs arising from the 
circulation, it was possible that ILCs also trafficked from skin (36) to peripheral LNs via the 
lymphatics, as observed for dermal DCs and LCs (37). To directly test this, photoconversion 
of  the entire CD45+ compartment of ear skin was established, enabling the analysis of 
cellular migration into the draining auricular LN (auLN) as well as identification of new cells 
moving into the ear skin (Fig. 4A, B). To directly test the migration of cells from the ear skin 
to the auLN, the ear was photoconverted and the auLN analysed 48 and 72 hrs later. A 
modest, but distinct Kaede Red+ population was detected within the auLN (Fig. 4C-E), with 
T cells, but not ILCs detected amongst this small migratory population (Fig. 4F, G). These 
data argue that under steady state conditions ILCs do not migrate from skin to peripheral 
LNs. To determine whether ILCs in skin only migrate to peripheral LNs during 
inflammation, the MC903-induced atopic dermatitis model (38) was established in Kaede 
mice, combining 5 days of MC903 ear painting with photoconversion of the skin. The short 
five day treatment was chosen to enable early changes in ILC populations to be assessed and 
caused a substantial increase in the size of the auLN, significant increases in ear thickness, 
and increased numbers of basophils and other hematopoietic cells in the ear skin including 
ILC2s (Fig. S12) (39). The draining auLN had increased substantially in cellularity, including 
the number of ILCs which had increased approximately 15-fold (Fig. 4H-J). Analysis of 
Kaede Red+ cells in the auLN revealed increased numbers of cells trafficking to the draining 
LN (Fig. 4K, L), which were mostly T cells but also ILCs (Fig. 4M, N). Detection of such 
few migratory ILCs compared with the substantial increases in all ILC subsets observed in 
the auLN (Fig. 4O), argued that migration through the lymphatics was unlikely to be the main 
mechanism increasing ILC numbers in the LN. Notably, ILCs had significantly increased 
their expression of Ki-67 (Fig. 4P) suggesting at least that the increased numbers of ILCs in 
the auLN reflect local expansion in situ.  
Combined, these data reveal that under steady state ILCs traffic from the circulation 
into peripheral LNs rather than through lymphatic drainage from the skin. Whilst 
inflammation in the skin can cause some ILCs to migrate to the draining LN, the substantial 
increase in ILC numbers reflects other mechanisms such as local proliferation and 
recruitment from the blood.  
 
Recruitment of ILCs into inflamed skin is dependent upon CCR6 
Simultaneous photolabelling of all the hematopoietic cells in the ear enabled 
migration of cells into the ear skin to be assessed. At 48 and 72 hrs post photoconversion, the 
proportion of Kaede Green+ CD45+ cells in the ear had significantly increased compared with 
0 hr controls, indicating the trafficking of new cells into this site at steady state (Fig. 5A, B), 
of which ILCs were a small (~3%) proportion (Fig. 5C, D). This may represent redistribution 
of ILCs within the skin, or trafficking of these cells from the following education in the 
draining LN (40). To test whether the recruitment of ILCs into skin was enhanced during 
inflammation, Kaede Green+ cells migrating into the ear after administration of MC903 was 
assessed. A significant increase in the number of Kaede Green+ CD45+ cells (Fig. 5E), T cells 
(Fig. 5F) and ILCs (Fig. 5G) were observed in MC903-treated mice versus vehicle control, 
suggesting that ILCs were recruited into the inflamed ear tissue. Over half of the population 
of Kaede Green+ ILCs lacked Ki-67 expression (Fig. 5H), arguing that the increase in Kaede 
Green+ ILCs was not solely attributable to proliferation. To investigate the potential 
mechanism regulating ILC recruitment to the inflamed tissue, we assessed CCR6 expression 
on ILCs given the proposed role of its ligand, CCL20 in regulating homing to the skin (41). 
Strikingly, while expression of CCR6 is restricted to ILC3s in the mLN, all ILC subsets 
isolated from ear skin or the auLN expressed CCR6, indicating that this might be a key 
mechanism by which these cells are recruited to the skin (Fig. S13). To directly test this 
CCR6-/- Kaede mice and WT Kaede mice were treated with MC903 as described above. 
Analysis of Kaede Green+ cells in the ear of CCR6-/- Kaede mice revealed a significant drop 
in the total number of CD45+ cells which included a significant decrease in the number of 
ILCs (Fig. 5I-L), indicating that CCR6 is important for the recruitment of ILCs into inflamed 
skin. 
 
ILC1s are a rapid source of IFN-γ in the draining LN after immunisation 
Combined, our data revealed that a migratory ILC1 population was present within 
peripheral LNs, alongside a population that remained resident in the tissue for at least 1 wk.   
The ability of cNK cells to rapidly produce effector cytokines is thought to modulate the 
microenvironment of the LN and shape the T cell responses generated in these tissues (42). 
Thus, we asked whether ILC1s in peripheral LNs also contributed to the rapid early release of 
cytokines in response to immunization. NK cell production of IFN-γ within the draining 
peripheral LNs was recently identified as a key mechanism through which the adjuvant AS01 
drives activation of DCs and the development of Th1 immunity (43). To assess whether the 
ILC1 population in peripheral LNs can also contribute to this early IFN-γ response, WT mice 
were immunized intramuscularly with the antigen OVA-2W1S, in the presence of PBS or 
with AS01. Consistent with the previous study, AS01 induced the rapid production of IFN-γ 
by NK1.1+CD3- cells in the draining LN within hrs of immunization (Fig. 6A). While the 
majority of the NK1.1+CD3- cells expressed Eomes, a distinct population of NK1.1+CD3-IL-
7Rα+Eomes- cells expressing T-bet were evident, thus revealing that ILC1s in the LN also 
release IFN-γ in response to AS01 (Fig. 6A, B). To confirm that this response had resulted in 
a Th1-skewed T cell response, analysis of 2W1S-specific CD4 T cells in the draining LN at 7 
days post immunization using MHCII tetramers revealed that the AS01 adjuvant had 
generated a robust Th1 effector T cell response (Fig. 6C, D). Finally, to determine whether 
the migratory and resident ILC1 populations showed functional differences in their 
production of IFN-γ, Kaede mice were immunised with OVA-2W1S in the presence of PBS 
or AS01, 72 hrs post photoconversion of the draining bLN. Both Kaede Green+ and Kaede 
Red+ ILC1 in the draining LN expressed IFN-γ (Fig. 6E), although numerically, there were 
significantly more Kaede Green+ ILC1s amongst the IFN-γ producing cells than Kaede Red+ 
ILC1 (Fig. 6F). The vast majority of IFN-γ produced by cNK cells came from Kaede Green+ 
cells (Fig. 6G). Therefore, both migratory and resident ILC1s appear able to functionally 
contribute to the shaping of adaptive immune responses within LNs through rapid effector 
cytokine release. 
Discussion 
Here we provide compelling evidence that peripheral LNs contain migratory ILC 
populations. Our studies revealed the balanced ingress and egress of ILCs from LNs with the 
majority of migratory ILCs belonging to the ILC1 subset over the time frame assessed. ILC1s 
are the most prevalent subset in murine circulation and like cNK cells, recirculate through 
peripheral LNs utilising CCR7 and CD62L to enter the tissue, whilst egressing in a S1P1 
dependent manner. Functionally, ILC1s in peripheral LNs were able to rapidly produce 
effector cytokines in response to immunization, as observed for cNK cells, supporting the 
initial priming of CD4 T cells. Combined, these data provide critical further insight into the 
behavior of ILCs within lymphoid tissues. 
Following their relatively recent identification (3), understanding the functions of 
ILCs within the immune system has become a key area of immunological research. Despite 
ILCs being present within all lymphoid tissues, direct evidence of their function here is very 
limited. Having established techniques to track the movement of cells into and out of 
peripheral LNs, we sought to understand more of the basic behavior of ILCs within these 
tissues in an effort to better understand their roles within such tissue. Photoconvertible mice 
provide a means of site specifically labelling cells and the direct assessment of cellular 
migration in vivo. Tracking ILCs within the photoconverted bLN over time revealed that 
within 72 hrs, approximately 50% of the ILCs had migrated into the tissue since 
photoconversion. Whilst the fluorescence level of Kaede Red protein will dilute as cells 
proliferate, the majority of ILCs within the LN were Ki-67- and expression of Kaede Red did 
not correlate with proliferation amongst ILC subsets. Although a clear caveat of the 
photoconvertible mouse models is the potential loss of the light-induced label, studying ILC 
migration under steady state conditions over a time frame of up to 1 wk helped to mitigate 
this problem. Treatment with the S1P1 agonist FTY720 resulted in the accumulation of ILCs 
within the LN, consistent with blocked egress. These data strongly indicated the balanced 
migration of ILCs into and out of peripheral LNs. Combined with our data detecting minimal 
ILC trafficking from skin to the draining peripheral LN, the detail of which ILC subsets 
migrate really reflects the composition of the ILC compartment within murine blood. Here, 
the majority of ILCs were of an ILC1 phenotype and expression of the key mechanisms 
required to enter LNs direct from the circulation (CD62L and CCR7) was detected. Only a 
minority of the ILC2 and ILC3 populations within the LN were found to be migratory over 1 
wk, indicating that bona fide LN resident ILC populations exist. These observations would 
have been strengthened by approaches facilitating the tracking of ILC populations for longer 
periods of time, but concerns regarding the potential loss of the photoconverted red form of 
the fluorochromes inhibited such studies. In the future, novel mice enabling ate mapping of 
cre recombinase activity induced through photoactivation might provide a superior approach 
to the long term tracking of tissue residency. 
Whilst the IL-7Rα+T-bet+Eomes- ILC1 population detected within LNs is 
developmentally distinct from cNK cells (44), it is striking that the data provided here reveals 
a similar migratory behavior. Direct comparison of the ‘helper’ ILC1 (17) and cNK cell 
migration indicated that cNK cells were more migratory, since a higher proportion of the 
cNK cells had newly entered the tissue within 72 hrs of labelling. Our data also provides 
direct evidence that both cNK cells and ILC1s recirculate through peripheral LNs, a behavior 
demonstrable in photoconvertible mice. While only a few labelled ILCs were detected within 
contralateral LNs this likely reflects the technical limitations of trying to track a population of 
a few hundred cells within the entire mouse and the larger cNK cell population was more 
readily detected, as were T cells. It remains possible however, that some ILCs exit peripheral 
LNs and traffic to tissues that were not assessed. The data presented here do not contradict 
published studies of parabiotic mouse models since here ILCs in the mLN and spleen, but not 
peripheral LNs, were assessed and lymphatic migration would not be captured (9). Consistent 
with these previous studies, our data also indicate that the ILC2 and ILC3 compartments of 
peripheral LNs contain resident populations. Interestingly, while both the Kaede and H2B-
Dendra2 mouse models indicated that the majority of ILC2s and ILC3s were tissue-resident, 
identification of ILC2s by GATA-3 expression in the H2B-Dendra2 mice did identify a 
sizeable migratory ILC2 population in the LNs (approximately 40% of total LN ILC2). Few 
ILC2 are present in LNs compared to tissues such as the lung and the role of these cells is 
unclear. Our data indicates that there is some movement of these cells between the circulation 
and peripheral LNs. The ILC3 subset displayed the least evidence of migratory behavior 
within the timeframe assessed and it remains possible that the cells present here are the 
remnants of the lymphoid tissue inducer population that initially seeded the LN anlagen in the 
embryo. 
The function of the helper ILC populations in LNs is poorly understood, whilst cNK 
cells have been considered to be key early producers of effector cytokines within the LN to 
support the initiation of T cell responses. NK cells were initially described as being 
specifically recruited into draining LNs (42) in response to immunization. Subsequent studies 
identified that cNK cells enter peripheral LNs via the HEVs in a CD62L- and CCR7-
dependent manner (27) and egress dependent upon S1P5 (32, 33). Thus increases in cNK cell 
numbers in the draining LN may reflect the restricted exit of cells to drive their accumulation, 
rather than enhanced recruitment. Here we demonstrate that both resident and migratory 
ILC1s rapidly produced IFN-γ in response to immunization, as described for cNK cells. 
Questions remain as to how migratory and resident ILC1s differ in their functions and 
whether LN ILC1s contribute to peripheral LNs beyond the roles described for cNK cells. 
Further studies and the degree to which ILC1s can contribute to Th1 priming in the absence 
of cNK cells needs to be tested. Given the location of cNK cells within LNs (45), it is likely 
that ILC1s may reside away from the interfollicular zone and border between the B and T cell 
areas, where ILC2s and ILC3s have been described (18).  
In summary, the data presented here sheds new light on the relationship between ILC 
populations within the circulation and peripheral lymphoid tissues, revealing that a murine 
ILC1 subset continuously traffics between the blood and peripheral LNs. Despite rapid 
advances in our understanding of how ILCs develop, much of their basic biology remains 
poorly understood and the dynamic changes in LN ILCs described here provides further 
insight into how these cells might contribute to the regulation of adaptive immunity in 
lymphoid tissues. 
 
  
Materials and Methods  
Study Design 
The main aims of this study were to understand the extent of ILC migration into and out of 
peripheral LNs and determine whether ILCs trafficked from skin into LNs. We sought to 
address these aims through specifically labelling ILCs in peripheral LNs and skin and test the 
extent to which ILCs entered and left these tissues and identify the sites to which these cells 
migrated. These was done using transgenic mice expressing green photoconvertible proteins 
which, when exposed to violet light, switched to a red fluorescence that could then be 
detected for a number of days post photoconversion. A key feature of the photoconversion 
performed was that this was optimised such that all cells in the target tissue (e.g. LN, or ear 
skin) simultaneously converted to the red fluorescent form. This enabled both the tracking of 
labelled red cells migrating to different sites as well detection of new cells (expressing the 
native green form of the photoconvertible) entering the tissue after labelling. The migration 
of ILCs was assessed under steady state conditions as well as in response to inflammation. 
 
Mice 
Animal husbandry and experiments were ethically reviewed and carried out in accordance 
with UK Home Office guidelines. C57BL/6, Kaede (28), C57BL/6 H2B-Dendra2 (35), 
Kaede CCR6-/-,and Kaede CCR7-/- mice were maintained and bred at the University of 
Birmingham Biomedical Services Unit. Mice were culled between the ages of 6-15 weeks.  
 
Experimental procedures 
To establish inflammation in the ear (MC903 AD model) 4 nmol of Calcipotriol (Tocris), in 
absolute ethanol (VWR Chemicals), was applied to the dorsal and ventral area of the ear for 5 
consecutive days. As a vehicle control absolute ethanol was used.  
 
Mice were injected intraperitoneally (i.p) with 1 mg/mL of FTY720 (in 200 µL H20) (Sigma). 
As a vehicle control mice were injected i.p. with H20. When FTY720 was administered in 
conjunction with bLN surgery or the MC903 model, mice were injected one day prior to the 
start of the procedure and every day during the procedure.  
 
For photoconversion of the bLN, mice were subcutaneously injected with 100 µL of 
analgesic buprenorphine 1 hr prior to surgery (Vetergesic, Reckitt Benckiser Healthcare). 
Under anesthesia via gaseous isoflurane, a small incision was made exposing the bLN to 
violet light (365 nm UV LED) for 3 minutes and 30 seconds. The skin was sutured together, 
and mice were subcutaneously injected with 500 µL of saline solution. 0 hr time points were 
culled immediately after surgery.  
 
For violet light conversion of the ear, under anaesthesia ears were exposed to a violet light 
(405nm UV laser) for 40 seconds with periodic breaks. Black cardboard was used to shield 
the rest of the mouse and 0 hr time points were culled immediately after photoconversion.  
 
Immunizations were performed under anesthesia, via gaseous isoflurane, using 2W1S peptide 
conjugated to OVA protein. The antigen and adjuvant were administered through 
intramuscular injections according to GSK standards, or through paw pad injections. Upon 
intramuscular injections the site of the injection, the gastrocnemius muscle, was shaved and 
approximately 3mm of the needle was inserted into the muscle. The injection volume of 10μl 
was administered into gastrocnemius muscle of both hind legs. The injections contained 20 
µg OVA-2W1S (Proimmune) and 1/50 Human Dose (HD) AS01B (i.e. 1 µg of each MPL and 
QS-21) or 20 µg OVA-2W1S and PBS. The 2W1S peptide is a variant of peptide 52-68 from 
the I-E alpha chain that is highly immunogenic in C57BL/6 mice (46). AS01 is a GSK-
proprietary Adjuvant System containing MPL, QS-21 and liposome. QS-21 (Quillaja 
saponaria Molina, fraction 21) is licensed by GSK from Antigenics LLC, a wholly owned 
subsidiary of Agenus Inc., a Delaware, USA corporation. For analysis at day 7, a second 
injection of OVA-2W with AS01 or PBS was administered 6 hrs prior to analysis of the 
response.  
 
Cell Culture 
In AS01 experiments, assessing the production of IFN-γ, cell suspensions were incubated for 
3h in culture media in the presence of brefeldin A (BFA) (10 µg/ml, BD Biosciences) and 
monensin (10 µg/ml, BD Biosciences) at 37°C 5% C02. 
 
Flow Cytometry 
Tissues were prepared using the same methods in Dutton et al. (47). LNs were cleaned and 
teased in Roswell Park Memorial Institute (RPMI) 1640 Medium (ThermoFisher Scientific) 
and crushed through a 70μm filter. Samples were centrifuged (5 minutes, 1,500 rpm, 4°C), 
supernatant removed and resuspended in appropriate amount of DPBS supplemented with 2% 
FBS and 0.5% EDTA. Ears were cut into small sections and agitated whilst incubated at 37°C 
in a thermomixer (Eppendorf) for 30 minutes in 1 ml of Liberase TM/DNase digestion 
solution (3 mls per ear; 3 ml Dulbecco’s Modified Eagle Media (DMEM, ThermoFisher 
Scientific) 75 µL Liberase TM (0.28 Wunsch units/mL) and 75µL DNase (200 mg/mL)). 
Tissue was then filtered through a 70 μm filter and washed with DMEM. The ear was then 
removed from the filter and this process repeated twice more. Following the third incubation 
the ear was crushed through the filter and washed with DMEM. Samples were centrifuged 
and suspended in an appropriate amount of DPBS supplemented with 2% FBS and 0.5% 
EDTA. 1-2mLs of blood was harvested, via cardiac puncture. Samples were centrifuged 
(5minutes, 2,000 rpm), supernatant removed and incubated in 500 µL of Gey’s solution (47) 
on ice for 5minutes. This was repeated twice more, before being resuspended in appropriate 
amount of DPBS supplemented with 2% FBS and 0.5% EDTA. Samples enriched for T and 
B cells were stained for B220 (APC), CD3 (APC) and CD5 (APC) for 30 minutes on ice 
followed by an enrichment with anti-APC MicroBeads (MACS). Samples enriched for 
CD45+ hematopoietic cells were enriched using CD45 MicroBeads (MACS). All samples 
were stained with a LIVE/DEAD cell viability assay in APC-Cy7 in PBS (1:1000) for 15 
minutes at 4°C. Extracellular staining was conducted with antibodies diluted in DPBS 
supplemented with 2% FBS and 0.5% EDTA for 30 minutes on ice. The Foxp3 fixation and 
permeabilization kit (eBioscience) was used to fix and intracellularly stain samples. Kaede 
samples did not undergo fixation and intracellular staining. The antibodies raised against the 
following mouse agents were used: B220 (clone RA3-6B2, 1:300 or 1:200, eBioscience), 
CCR6 (clone 29-2L17, 1:100, BioLegend), CCR7 (clone 4B12, 1:100, eBioscience), CD3ε 
(clone 145-2C11 or eBio500A2 or 17A2, 1:100 or 1:200, eBioscience or BD Horizon or 
BioLegend), CD4 (clone RM4-5, 1:100, BioLegend), CD5 (clone 53-7.3, 1:100 or 1:200, 
eBioscience), CD11b (clone M1/70, 1:300 or 1:200, eBioscience), CD11c (clone N418, 1:300 
or 1:200, eBioscience or BioLegend), CD19 (clone eBio1D3, 1:200, eBioscience), CD25 
(clone PC61, 1:50, eBioscience), CD31 (clone, 1:400,  eBioscience), CD45.2 (clone 104, 
1:100, BioLegend), CD49b (clone DX5, 1:200, eBioscience), CD62L (clone MEL/14, 1:1500 
or 1:500 or 1:100, eBioscience or BioLegend), CD69 (clone H1.2F3, 1:100, eBioscience), 
CD103 (clone, 1:200, BioLegend) CD123 (clone 5B11, 1:500, eBioscience), CD207 (clone 
4C7, 1:100, BioLegend), c-kit (clone H57-597, 1:100, eBioscience), EOMES (clone 
Dan11mag, 1:50, eBioscience), F4/80 (clone BM8, 1:200, eBioscience), FcεRI (clone MAR-
1, 1:200, eBioscience), GATA-3 (clone TWAJ, 1:75, eBioscience), gp38 (clone, 1:1000, 
BioLegend), Gr-1 (clone RB6-8C5, 1:2000, eBioscience), IL-7Rα (clone A7R34, 1:50, 
BioLegend), Ki-67 (clone SolA15, 1:400, eBioscience), KLRG1 (clone 2F1, 1:200, 
BioLegend or eBioscience), MHCII (clone M5/114.15.2, 1:100, eBioscience), NK1.1 (clone, 
1:100 or 1:200, eBioscience or BD Horizon) NKp46 (clone 29A1.4, 1:50 or 1:100, 
BioLegend or eBioscience), RORγ (clone AFKJS-9, 1:100, eBioscience), T-bet (clone 
eBio4B10, 1:50, eBioscience), TCRβ (clone H57-597, 1:100, BioLegend), TCRγδ (clone 
GL3, 1:200, BD Horizon) and TER119 (clone TER-119, 1:200 or 1:100, eBioscience). To 
identify ILCs the lineage channel included (B220, CD11b, CD11c, CD3, CD5, CD19, 
TER119, Gr-1, CD123, F4/80, FcεRI, CD49b). CD123 was not included in the lineage 
channel when identifying ILCs in Kaede mice. Samples were run on the BD LSRFortessaTM 
X-20 (BD Biosciences) and data collected using BD FACSDiva Software (BD biosciences). 
 
Gene expression analysis 
FACS-sorted NK1.1+/- ILCs were lysed in RLT buffer (Qiagen) and total RNA was 
subsequently isolated using Quick-RNA Microprep kit according to the manufacturer’s 
instructions (Zymo Research). cDNA was generated from total RNA in a reverse 
transcription reaction using random primers. TaqMan gene expression assays for selected 
genes (Applied Biosystems; S1pr1 (Mm00514644_m1), S1pr2 (custom plus TaqMan RNA 
assay) S1pr3 (Mm04229896_m1), S1pr4 (Mm00468695_s1) and S1pr5 (Mm02620565_s1) 
were prepared using the Taqman PreAmp Master Mix Kit. Samples were then analysed on 
QuantStudio 12K Flex RT-PCR system. qPCR results were analysed using the R 
environment for statistical computing. Delta-delta (ΔΔCT) values were calculated using the 
mean of three reference genes (b-actin, glyceraldehyde 3-phosphate dehydrogenase, and 18S 
ribosomal DNA). Fold changes were determined by calculating power 2-ΔΔCT. 
 
Statistical analysis 
Data collected were analysed using Flow Jo 10.4.2 software (Treestar) and GraphPad Prism 
7. Normal distribution of the data was not assumed. Pairs of samples were compared using an 
unpaired two-tailed Mann-Whitney T test. When comparing more than two sets of data 
statistical significance was tested using Kruskal-Wallis one-way ANOVA with post hoc 
Dunn’s test: *p≤0.05, **p≤0.01, ***p≤0.001. The bar represents the median and where 
appropriate the median has been shown numerically. Where a p value is not indicated, no 
statistical difference was observed. The percentage of Kaede Green+ cells cannot be 
statistically compared to Kaede Red+ cells within a population, therefore no statistical 
analysis was done on these data.  
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Figure Captions 
Figure 1. CCR7-dependent entry of ILCs into peripheral LNs 
To assess the migratory kinetics of different cellular populations within peripheral LNs, the 
bLN of Kaede mice was photoconverted and analysed 72 hrs later. (A) Expression of Kaede 
Green versus Kaede Red protein by CD45+ cells isolated from the bLN at 72 hrs post 
photoconversion. (B) Percentage of CD45+ cells expressing Kaede Green or Kaede Red 
protein at 72 hrs post photoconversion (n=10). (C) Characterisation of Kaede Green+ CD45+ 
cells isolated from the bLN, showing ⍺β T cells (CD45+ CD3+ TCRβ+ TCR𝛾𝛾δ-), 𝛾𝛾δ T cells 
(CD45+ CD3+ TCRβ- TCR𝛾𝛾δ+), ILCs (CD45+ IL-7R⍺+ Lin{B220, CD11b, CD11c, CD3, 
CD5, CD19, Ter119, Gr1, CD49b, F4/80, Fc𝜀𝜀RI}-) and LCs (CD45+ MHCII+ CD11c+ 
CD207+). (D) Percentage of ⍺β T cells (n=7), 𝛾𝛾δ T cells (n=7), ILCs (n=10) or LCs (n=5) 
amongst CD45+ Kaede Green+ cells. (E) Characterisation of Kaede Red+ cells isolated from 
the bLN, showing ⍺β T cells, 𝛾𝛾δ T cells, ILCs and LCs. (F) Percentage of ⍺β T cells (n=7), 
𝛾𝛾δ T cells (n=7), ILCs (n=10) and LCs (n=5) amongst CD45+ Kaede Red+ cells. Expression 
of Kaede Green versus Kaede Red protein by ⍺β T cells, 𝛾𝛾δ T cells, ILCs and LCs isolated 
from the bLN of (G) Kaede and (H) CCR7-/- Kaede mice. (I) Number of ⍺β T cells (WT n=7, 
CCR7-/- n=8), 𝛾𝛾δ T cells (WT n=7, CCR7-/- n=8), ILCs (WT n=6, CCR7-/- n=8) and LCs 
(WT=5, CCR7-/- n=7) isolated from the bLN of WT Kaede versus CCR7-/- Kaede mice. (J) 
Number of Kaede Green ⍺β T cells (WT n=7, CCR7-/- n=8), 𝛾𝛾δ T cells (WT n=7, CCR7-/- 
n=8), ILCs (WT n=7, CCR7-/- n=8) and LCs (WT n=5, CCR7-/- n=7) isolated from the bLN. 
Data are pooled from a minimum of 2 independent experiments. Values on flow cytometry 
plots represent percentages, bars on scatter plots represents the median, which is also shown 
numerically. Statistical significance was tested using an unpaired, non-parametric, Mann-
Whitney two tailed T test: *p≤0.05, **p≤0.01, ***p≤0.001. 
  
Figure 2. ILC frequency in LNs is maintained by balanced ingress and egress. 
To further investigate the migratory ILCs identified within the labelled bLN, the effect of 
photoconversion on the number of ILCs was assessed. (A) Expression of Kaede Green versus 
Kaede Red protein by ILCs (CD45+ IL-7R⍺+ Lin{B220, CD11b, CD11c, CD3, CD5, CD19, 
Ter119, Gr1, CD49b, F4/80, Fc𝜀𝜀RI}-) isolated from the bLN of control Kaede mice (no 
photoconversion) and Kaede mice at 72 hrs post photoconversion. (B) The number of Kaede 
Green+ and Kaede Red+ ILCs recovered from the bLN of control (n=6) versus 
photoconverted bLNs at 72 hrs post labelling (n=10). To investigate egress of ILCs from the 
bLN, Kaede mice were maintained on vehicle control (H2O) or FTY720, the bLN was 
photoconverted and then analyzed 72 hrs later. (C) Representative flow cytometry plots 
showing expression of Kaede Green versus Kaede Red protein by ILCs in the bLN 72 hrs 
after photoconversion. (D) Percentage of Kaede Green+ or Kaede Red+ ILCs in the bLN of 
Ctrl (n=4) and FTY720 (n=7) mice. (E) Total numbers of Kaede Green+ and Kaede Red+ 
ILCs in the bLN. To assess whether ILCs recirculate through peripheral LNs, the 
contralateral LNs of Kaede mice were analysed at 72 hrs post photoconversion of the bLN, 
with combined B- and T-cell depletion used to enrich for ILCs. (F) Expression of Kaede 
Green versus Kaede Red protein by ILCs (CD45+ IL-7R⍺+ Lin{B220, CD11b, CD11c, CD3, 
CD5, CD19, Ter119, Gr1, CD49b, F4/80, Fc𝜀𝜀RI}-) isolated from contralateral LNs. 
Percentage of Kaede Red+ ILCs (G) and T cells (H) in WT Kaede (n=14) and CCR7-/- Kaede 
(n=8) contralateral LNs. (I) Representative flow cytometry plots of Kaede Green+ (left) and 
Kaede Red+ (right) ILC expression of CD69. (J) Percentage of Kaede Green+ and Kaede 
Red+ ILCs expressing CD69 (n=7).  Data are pooled from 2 independent experiments. Bars 
on scatter plots represents the median, which is also shown numerically. Statistical 
significance was tested using an unpaired, non-parametric, Mann-Whitney two tailed T test: 
**p≤0.01, ***p≤0.001. 
 Figure 3. ILC1s traffic through peripheral LNs from the circulation 
To test whether all ILC subsets showed an equal ability to traffic through the peripheral LNs, 
an established panel of surface markers was used to identify which ILC subsets were 
migrating into the bLN. (A) Representative flow cytometry plots showing identification of 
ILC1 (CD45+ Lin{B220, CD11b, CD11c, CD3, CD5, CD19, Ter119, Gr1, CD49b, F4/80, 
Fc𝜀𝜀RI}- IL-7Rα+ CD4- (NK1.1, NKp46)+), ILC2 (CD45+ Lin{B220, CD11b, CD11c, CD3, 
CD5, CD19, Ter119, Gr1, CD49b, F4/80, Fc𝜀𝜀RI}-IL-7Rα+ CD4- (NK1.1, NKp46)-(KLRG-1, 
CD25)+), and ILC3 (CD45+ Lin{B220, CD11b, CD11c, CD3, CD5, CD19, Ter119, Gr1, 
CD49b, F4/80, Fc𝜀𝜀RI}-IL-7Rα+ CD4+) subsets in the bLN. (B) The percentage of each ILC 
subset identified within the bLN of Kaede mice using the surface marker staining.  
(C-D) Kaede Green versus Kaede Red protein expression by ILC1s, ILC2s and ILC3s at 72 
hrs and 1 week after photoconversion of the bLN. (E) The percentage of Kaede Green+ and 
Kaede Red+ ILC1s, ILC2s and ILC3s in the bLN at 72 hrs and 1 week post photoconversion. 
Data are pooled from 2 independent experiments, n = 7. To investigate the source of ILC1s 
migrating into the bLN, ILC populations in murine blood were analysed. (F) Representative 
flow cytometry plots showing identification of putative ILC1s (CD45+ IL-7R⍺+ 
(NKp46NK1.1)+Lin{B220, CD11b, CD11c, CD3, CD5, CD19, Ter119, Gr1, CD49b, F4/80, 
Fc𝜀𝜀RI}-) and ILC2s (CD45+ IL-7R⍺+ NK1.1- NKp46- KLRG-1+ Lin-). (G) The proportion of 
ILC1s and ILC2s within the ILC population isolated from the blood, n = 8. (H) 
Representative flow cytometry plots showing expression of T-bet versus GATA-3 by blood 
ILCs. To isolate sufficient numbers of ILCs, blood samples from 3 mice were enriched for 
the CD45+ fraction separately and then pooled for staining and analysis. (I) Representative 
flow cytometry plots showing expression of CD62L and CCR7 by T-bet+ ILC1s versus T-bet- 
ILCs isolated from blood. All data are pooled from 2 independent experiments. Values on 
flow cytometry plots represent percentages, bars on scatter plots represents the median. 
Statistical significance was tested using an unpaired, non-parametric, Mann-Whitney two 
tailed T test: *p≤0.05, **p≤0.01, ***p≤0.001.     
 
Figure 4. Minimal ILC migration from skin to the draining LN even under conditions of 
inflammation 
To directly test whether ILCs migrate from skin to peripheral LNs, the ears of Kaede mice 
were photoconverted and the presence of labelled cells assessed in the auLN. (A) Expression 
of Kaede Green versus Kaede Red protein by CD45+ cells isolated from ear skin without (left 
panel) or immediately after (right panel) photoconversion. (B) Percentage of CD45+ cells 
expressing Kaede Red protein in the ear and auLN immediately after photoconversion 
(n=12). (C) Expression of Kaede Green versus Kaede Red protein by CD45+ cells in the 
auLN at 0, 48 and 72 hrs after photoconversion of the ear skin. The percentage (D) and total 
number (E) of Kaede Red+ CD45+ cells in the auLN over the time course of 0 hrs (n=12), 48 
hrs (n=11) and 72 hrs (n=10). (F) Representative flow cytometry plots assessing the 
phenotype of Kaede Red+ CD45+ cells in the auLN, with identification of T cells (CD3+), 
ILCs (IL-7R⍺+ Lin{B220, CD11b, CD11c, CD3, CD5, CD19, Ter119, Gr1, CD49b, F4/80, 
Fc𝜀𝜀RI}-) and LCs (CD45+ MHCII+ CD11c+ CD207+). (G) Percentage of Kaede Red+ CD45+ 
cells in the auLN that were T cells (n=5), ILCs (n=12) and LCs (n=5). To determine whether 
inflammation in the skin resulted in the migration of ILCs to the draining LN, the ears of 
mice were treated with vehicle control (VC) or MC903, with photoconversion of the ear after 
48 hrs of treatment. (H) Representative flow cytometry plots showing ILCs within VC (left) 
and MC903 (right) treated auLN. Enumeration of CD45+ cells (I) and ILC (J) recovered from 
the auLN of mice treated with VC (n=7) or MC903 (n=12). (K) Representative flow 
cytometry plots assessing the phenotype of Kaede Red+ CD45+ cells in the auLN of MC903 
treated mice, with the identification of T cells and ILCs. Enumeration of Kaede Red+ (L) 
CD45+ cells in VC (n=8) or MC903 (n=8), (M) T cells in VC (n=10) or MC903 (n=11) and 
(N) ILC in VC (n=8) or MC903 (n=8) within the auLN. (O) Enumeration of ILC subsets in 
the auLN of mice treated with vehicle control (VC, n=6) and MC903 (n=15). (P) Expression 
of Ki-67 by ILCs in the auLN of mice treated with VC (n=6) or MC903 (n=7). Data are 
pooled from a minimum of 2 independent experiments. Values on flow cytometry plots 
represent percentages, bars on scatter plots represents the median, which is also shown 
numerically. Pairs of samples were compared using an unpaired Mann-Whitney T test, when 
comparing more than two sets of data statistical significance was tested using Kruskal-Wallis 
one-way ANOVA with post hoc Dunn’s test: *p≤0.05, **p≤0.01, ***p≤0.001. 
  
Figure 5. CCR6-dependent recruitment of ILCs into the inflamed ear 
To investigate mechanisms controlling the recruitment of ILCs into the ear, the entire ear 
CD45+ population was labelled through photoconversion, with Kaede Green+ cells identified 
at subsequent time points as cells that had newly entered the tissue. (A) Expression of Kaede 
Green versus Kaede Red protein by CD45+ cells in the ear at 0, 48 and 72 hrs after 
photoconversion of the ear skin. (B) The percentage (left) and total number (right) of Kaede 
Green+ CD45+ cells in the auLN over the time course of 0 hrs (n=12), 48 hrs (n=11) and 72 
hrs (n=11). (C) Representative flow cytometry plots assessing the phenotype of Kaede 
Green+ CD45+ cells in the ear with identification of T cells (CD3+), ILCs (IL-7R⍺+ Lin{B220, 
CD11b, CD11c, CD3, CD5, CD19, Ter119, Gr1, CD49b, F4/80, Fc𝜀𝜀RI}-) and LCs (CD45+ 
MHCII+ CD11c+ CD207+). (D) Percentage of Kaede Green+ CD45+ cells in the ear that were 
T cells (n=6), ILCs (n=11) and LCs (n=6). To assess migration under inflammatory 
conditions MC903 was applied to the ears for 5 consecutive days to induce atopic dermatitis, 
with photoconversion of the ear 48 hrs after treatment was started. Number of Kaede Green+ 
(E) CD45+ cells in VC (n=9) or MC903 (n=7), (F) T cells in VC (n=10) or MC903 (n=8) and 
(G) ILCs in VC (n=9) or MC903 (n=7) within the ear. (H) Representative flow cytometry 
plots of Kaede Green+ ILCs Ki-67 expression within the ear of VC and MC903 treated mice. 
To test the requirement for CCR6 in ILC recruitment into the ear, MC903 was applied to the 
ears of Kaede and CCR6-/- Kaede mice for 5 consecutive days to induce atopic dermatitis, 
with photoconversion of the ear 48 hrs after treatment was started. (I) Expression of Kaede 
Green and Kaede Red protein by CD45+ cells within MC903 treated ears. (J) Number of 
Kaede Green+ CD45+ cells (Kaede n=8, CCR6-/- Kaede n=9). (K) Representative flow 
cytometry plots showing Kaede Green+ ILCs. (L) Number of Kaede Green+ ILC (Kaede n=8, 
CCR6-/- Kaede n=9). Each data point represents cells isolated from 1 ear and 1 auLN. Data 
are pooled from a minimum of 2 independent experiments. Values on flow cytometry plots 
represent percentages, bars on scatter plots represents the median, which is also shown 
numerically. Pairs of samples were compared using an unpaired Mann-Whitney T test, when 
comparing more than two sets of data statistical significance was tested using Kruskal-Wallis 
one-way ANOVA with post hoc Dunn’s test: *p≤0.05, **p≤0.01, ***p≤0.001. 
 
Figure 6. ILC1s in the draining LN are a rapid source of IFN-γ after immunization. 
To investigate the function of ILC1 within peripheral LNs, mice were injected 
intramuscularly with 20 µg OVA-2W1S/PBS or 20 µg OVA-2W1S/AS01 and culled either 6 
hrs post immunization to assess the early innate IFN-𝛾𝛾 response or after 7 days following a 
second immunization performed 6 hrs prior to analysis. (A) Representative flow 
cytometry plots showing inguinal LN cells from mice given OVA-2W1S/PBS (top) or OVA-
2W1S/AS01 (bottom), with identification of different IFN-𝛾𝛾 producing populations including 
cNK cells (CD45+ IFN𝛾𝛾+ CD3𝜀𝜀- NK1.1+EOMES+) and ILC1s (CD45+ IFN𝛾𝛾+ CD3𝜀𝜀- NK1.1+ 
EOMES- T-bet+) shown. (B) Total number of IFN𝛾𝛾+ ILC1s and cNK cells in OVA/ASO1 
treated mice (n=5). (C) Representative flow cytometry plots showing IFN-γ production by 
2W1S-specific CD4 T cells at day 7 post initial immunization with (AS01) or without (PBS) 
the adjuvant AS01. (D) Total number of IFN-γ producing 2W1S-specific CD4 T cells in the 
draining inguinal LN of PBS (n=4) and AS01 mice (n=6). To test whether both migratory and 
resident ILC1 subsets were able to produce IFN-γ, the bLN of Kaede mice was 
photoconverted and 3 days later mice were then immunized in the paw pad with either 20 
µg OVA-2W1S/PBS or 20 µg OVA-2W1S/AS01 and analysed 6 hrs later. (E) Representative 
flow cytometry plots showing bLN cells from mice given OVA-2W1S/PBS (top) or OVA-
2W1S/AS01 (bottom), with identification of ILC1 and cNK populations producing IFN-𝛾𝛾 and 
their expression of Kaede Green versus Kaede Red protein. (F)  Percentage Kaede Green 
(migratory) and Kaede Red (resident) ILC1s and cNK cells amongst IFN-γ producing cells. 
(G)  Total numbers of IFN-γ+ ILC1s and cNK cells expressing either Kaede Green 
(migratory) or Kaede Red (resident). All sets of data are pooled from 2 independent 
experiments. Values on flow cytometry plots represent percentages, bars on scatter plots 
represents the median, which is also shown numerically. Statistical significance was tested 
using an unpaired, non-parametric, Mann-Whitney two tailed T test: *p≤0.05, **p≤0.01, 
***p≤0.001. 
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Figure S1.  LN stromal populations remain Kaede Red+ after photoconversion.  
To assess the migratory kinetics of different cellular populations within peripheral LNs, the 
bLN of Kaede mice was photoconverted and analyzed 72 hrs later. (A) Expression of Kaede 
Green and Kaede Red protein by CD45+ cells isolated from the bLN without (left panel) or 
immediately after (right panel) photoconversion. (B) Percentage of CD45+ cells in the bLN 
expressing Kaede Green (KG) and Kaede Red (KR) protein immediately after 
photoconversion (n=8). To assess a non-migratory cell population within the LN, the bLN 
was photoconverted and the stroma analyzed at 72 hrs post photoconversion. (C) Flow 
cytometry plots identifying stromal cells within the bLN, with blood endothelial cells (BECs), 
fibroblastic reticular cells (FRCs) and lymphatic endothelial cells (LECs) identified using 
GP38 versus CD31 expression. (D) Kaede Green versus Kaede Red expression by total 
CD45- stroma. (E) Percentage of stromal cells expressing Kaede Green or Kaede Red 
(n=7). (F) Representative Kaede Green versus Kaede Red expression by BECS, FRCs and 
LECs. (G) Percentage of BECs, FRCs and LECs expressing Kaede Green or Kaede Red 
(n=7). Data are pooled from a minimum of 2 independent experiments. Values on flow 
cytometry plots represent percentages, bars on scatter plots represents the median. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2.  ILCs continuously traffic into LNs with different kinetics to T cells.  
To further understand the kinetics of ILC migration through LNs, photoconverted bLNs were 
analysed at multiple time points post labelling and ILC and T cell populations compared for 
expression of Kaede Red and Kaede Green protein. (A) Expression of Kaede Green and 
Kaede Red protein by T cells (CD3+CD45+, upper panels) and ILC (CD45+IL-7R⍺+ Lin{B220, 
CD11b, CD11c, CD3, CD5, CD19, Ter119, Gr1, CD49b, F4/80, Fc𝜀𝜀RI}-, lower panels) 
isolated from the bLN at different times post photoconversion. (B) Percentage of Kaede 
Green+ T cells (upper panel) and ILC (lower panel) at 24hrs (n=5), 48hrs (n=5) and 96hrs 
(n=6) post photoconversion. Data are pooled from 2 independent experiments. Values on 
flow cytometry plots represent percentages, bars on scatter plots represent the median. 
Statistical significance was tested using an unpaired, non-parametric, Mann-Whitney two 
tailed U test: *p≤0.05, **p≤0.01, ***p≤0.001. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3.  Photoconversion does not cause an increase in the number of ILCs within 
the labelled bLN.  
To determine the effect of the surgical process and photoconversion, the cellularity and ILC 
composition of the bLN in WT control mice was compared with that of mice that underwent 
surgery (skin incision and exposure to violet light). (A) Percentage of CD45+ cells, ILCs 
(CD45+IL-7Rα+Lin {B220, CD11b, CD11c, CD3, CD5, CD19, Ter119, Gr1, CD49b, F4/80, 
Fc𝜀𝜀RI}-) and ILC subsets (identified by transcription factor expression) in control mice (n=6) 
and surgery (‘violet light’) mice (n=7). (B) Total number of CD45+ cells, ILCs, and ILC 
subsets in control mice (n=6) and surgery (‘violet light’) mice (n=7). Data are pooled from 2 
independent experiments. Values on flow cytometry plots represent percentages, bars on 
scatter plots represent the median. Statistical significance was tested using an unpaired, 
non-parametric, Mann-Whitney two tailed U test: *p≤0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4. Expression of S1P1 by ILC subsets in the bLN.  
To investigate expression of molecules associated with egress from LNs, S1P1 expression 
was analyzed on all ILC subsets. (A) Representative flow cytometry plots showing the 
expression of S1P1 on ILC1s, ILC2s, ILC3s and TrN cells in the bLN, compared to an 
isotype control. (B) Percentage (left) and total number (right) of ILC subsets expressing 
S1P1 in the bLN. Data are pooled from 2 independent experiments. Values on flow 
cytometry plots represent percentages, bars on scatter plots represent the median. 
Statistical significance was tested using Kruskal-Wallis one-way ANOVA with post hoc 
Dunn’s test: * p ≤ 0.05, ** p ≤0.01, *** p ≤ 0.005.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S5. Treatment with FTY720 results in ILC accumulation within the bLN.  
To assess the egress of ILC from peripheral LNs, photoconversion of the bLN of Kaede mice 
given vehicle control or FTY720 was performed. (A) Representative flow cytometry plots 
showing identification of ILC and T cells in the bLN. (B) Total numbers of CD45+ cells, T 
cells and ILC in the bLN at 72 hrs post photoconversion in the presence of the vehicle 
control (n=4) or FTY720 (n=5). 
To confirm the in vivo effects of FTY720 treatment, the T cell compartment was assessed. 
(C) Representative flow cytometry plots showing expression of Kaede Green versus Kaede 
Red protein by T cells in the bLN 72 hrs after photoconversion. (D) Percentage of Kaede 
Green+ and Kaede Red+ T cells in the bLN of Ctrl (n=4) and FTY720 (n=7) mice. (E) Total 
numbers of Kaede Green+ and Kaede Red+ T cells in the bLN of control (n=4) and FTY720 
(n=7) mice. (F) Expression of Kaede Green versus Kaede Red by T cells in the contralateral 
LNs. (G) Percentage and total number of Kaede Red+ T cells in the contralateral LNs in the 
presence of vehicle control (n=5) and FTY720 (n=7). Data are pooled from 2 independent 
experiments. Values on flow cytometry plots represent percentages, bars on scatter plots 
represent the median. Statistical significance was tested using an unpaired, non-parametric, 
Mann-Whitney two tailed U test: *p≤0.05, **p≤0.01. 
 
 
 
 
 
 
 
 
Figure S6. Analysis of S1PR expression by ILCs. 
To assess S1PR expression by ILC in peripheral LNs, (NK1.1+) ILC1 and (NK1.1-) ILC were 
isolated by FACS from a pool of peripheral LNs and assessed by qRT-PCR using TaqMan 
Gene Expression Assays. (A) Relative expression of S1PRs by ILC1 versus other ILC. (B) 
Relative expression of IFNγ, T-bet, and CD62L by ILC1 versus other ILC. The mRNA level of 
each gene was normalized using the mean of three reference genes (18S, GAPDH and b-
actin). Statistical significance was evaluated using a paired, parametric, two tailed U test: 
*p≤0.05, **p≤0.01. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S7. Identification of ILC subsets within the bLN. 
To ensure optimal identification of ILC subsets within the LNs of photoconvertible mice, a 
flow cytometry panel reliant on cell surface markers was validated and compared with subset 
identification with the transcription factors, GATA-3, ROR𝛾𝛾t, T-bet and EOMES. When 
identifying ILC the following Lineage cocktail was used; B220, CD11b, CD11c, CD3, CD5, 
CD19, Ter119, Gr1, CD49b, F4/80 and Fc𝜀𝜀RI. (A) Flow cytometry plots of ILC subsets within 
the bLN and EOMES expression on ILC1s. (B) Percentage of ILC1s that are EOMES+ or 
EOMES- (n=4).  
To identify ILC subsets within the bLN, samples were stained with TF and cell surface 
markers to identify and validate the gating strategy. (C) Flow cytometry plots showing gating 
strategy used to identify ILC subsets with TF (top) and cell surface (CS) markers (bottom); 
ILCs identified by CS markers are indicated with a ‘CS’. (D) Comparison of numbers of ILC 
subsets identified by TFs or CS markers (n=8). (E) Percentage of T-bet+, GATA-3+, ROR𝛾𝛾t+, 
and no TF expression (TrN) ILC1sCS, ILC2sCS ILC3sCS and Ungated cells (n=7). Each data 
point represents cells isolated from 1 bLN from one mouse. Data are pooled from a minimum 
of 2 independent experiments. Bars on scatter plots represents the median, which is also 
shown numerically. Pairs of samples were compared using a two-tailed Mann-Whitney U 
test; multiple samples were compared using Kruskal-Wallis one-way ANOVA with post hoc 
Dunn’s test: * p ≤ 0.05, ** p ≤0.01, *** p ≤ 0.005.  
 
 
 
 
 
 
Figure S8. Analysis of ILC residency in LNs using H2B-Dendra2 mice. 
To further assess the migratory abilities of the ILC subsets within LNs, photoconversion of 
the bLN of H2B-Dendra2 mice was performed and mice analyzed at 72 hrs and 1 week post 
photoconversion. ILC subsets within the bLN ILC were assessed by expression of the 
transcription factors GATA-3, ROR𝛾𝛾t and T-bet. When identifying ILC the following Lineage 
cocktail was used; B220, CD11b, CD11c, CD3, CD5, CD19, Ter119, Gr1, CD49b, F4/80 and 
Fc𝜀𝜀RI. (A) Flow cytometry plots of ILC subsets within the bLN. (B) Representative flow 
cytometry plots of ILC Dendra2 expression post photoconversion. (C) Percentage of 
Dendra2 Red+ (DR+) ILCs within the bLN. (D) Representative flow cytometry plots of ILC1 
Dendra2 expression post photoconversion. (E) Percentage of DR+ ILC1s within the bLN. (F) 
Representative flow cytometry plots of ILC2 Dendra2 expression post photoconversion. (G) 
Percentage of DR+ ILC2s within the bLN. (H) Representative flow cytometry plots of ILC3 
Dendra2 expression post photoconversion. (I) Percentage of DR+ ILC3s within the bLN. 
Each data point represents cells isolated from 1 bLN from one mouse. Data are pooled from 
a minimum of 2 independent experiments. Bars on scatter plots represents the median. 
Samples were compared using Kruskal-Wallis one-way ANOVA with post hoc Dunn’s test: * 
p ≤ 0.05, ** p ≤0.01, *** p ≤ 0.005.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S9. Differences in Dendra Red expression by ILC2 dependent upon 
identification by transcription factor or cell surface marker expression. 
To compare the differences between the migratory properties of ILC2s identified by cell 
surface (CS) markers or by transcription factors (TF), the bLN of H2B-Dendra2 mice was 
photoconverted and assessed 72 hrs later. When identifying ILC the following Lineage 
cocktail was used; B220, CD11b, CD11c, CD3, CD5, CD19, Ter119, Gr1, CD49b, F4/80 and 
Fc𝜀𝜀RI. (A) Representative flow cytometry plots identifying ILC2s via CS markers (ILC2CS) 
(IL-7R⍺+ Lineage- CD4- (NK1.1+ NKp46+)- (KLRG1+ CD25+)+), ILC2s via TF (ILC2sTF) (IL-
7R⍺+ Lineage- GATA-3+) and ILC2s within the ungated fraction of the CS marker gating via 
TFs (ILC2CS->TF) (IL-7R⍺+ Lineage- CD4- (NK1.1+ NKp46+)- (KLRG1+ CD25+)- GATA-3+). (B) 
Representative flow cytometry plots showing Dendra Green and Dendra Red expression of 
ILC2CS, ILC2TF and ILC2CD->TF. (C) Dendra expression of ILC2CS, ILC2TF and ILC2CS->TF. Each 
data point represents cells isolated from 1 bLN from one mouse. Bars on scatter plots 
represents the median. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S10. Expression of Ki-67 by ILC subsets within the bLN. 
To investigate proliferation rates amongst ILC subsets within the bLN, expression of Ki-67 
was analyzed. When identifying ILC the following Lineage cocktail was used; B220, CD11b, 
CD11c, CD3, CD5, CD19, Ter119, Gr1, CD49b, F4/80 and Fc𝜀𝜀RI. (A) Flow cytometry plots 
of ILC subsets within the bLN, cells first gated on live CD45+ cells. (B) Flow cytometry plots 
showing representative Ki-67 expression by ILC1, ILC2, ILC3. (C) Percentage Ki-67 
expression by ILC1, ILC2 and ILC3 (n=4). Data are representative of 2 independent 
experiments. Bars on scatter plots represents the median.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S11. Comparison of ILC1 and NK cell recirculation through peripheral lymph 
nodes. 
The ability of ILC1 to recirculate through peripheral LNs was compared with that of NK cells. 
The bLN was photoconverted and then assessed, alongside contralateral peripheral LNs 72 
hrs later. (A) Representative flow cytometry plots showing identification of ILC1 and NK cells 
in the labelled bLN and their expression of Kaede Red versus Kaede Green protein. (B) The 
percentage of ILC1 expressing Kaede Red or Kaede Green. (C) Percentage of NK cells 
expressing Kaede Red or Kaede Green. (D) Representative flow cytometry plots showing 
identification of ILC1 and NK cells in contralateral LNs and their expression of Kaede Red 
versus Kaede Green protein. (E) Percentage of NK cells and ILC1 expressing Kaede Red 
protein in contralateral LNs. (F) Total number of NK cells and ILC1 expressing Kaede Red 
protein in contralateral LNs. Data (n=6) from 1 independent experiment. Values on flow 
cytometry plots represent percentages, bars on scatter plots represent the median, which is 
also shown numerically. Statistical significance was tested using an unpaired, non-
parametric, Mann-Whitney two tailed U test: *p≤0.05, **p≤0.01. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S12. Induction of atopic dermatitis causes an increase in the frequency of ILC2 
in ear skin. 
To investigate the potential migration of ILC from inflamed skin to the draining auLN, MC903 
was applied to the ears of WT mice for 5 consecutive days to induce atopic dermatitis. (A) 
Ears of mice after application of the vehicle control (VC) (left) or MC903 (right) on the ear. 
(B) auLN of mice after application of the VC (top) or MC903 (bottom) on the ear. (C) 
Thickness of the ear skin of mice treated with VC or MC903. (D) Total number of basophils 
in the ear and auLN of mice treated with vehicle control (VC, n=7) or MC903 (n=12). (E) The 
number of CD45+ cells and ILCs in the ear of mice treated with vehicle control (VC, n=7) or 
MC903 (n=12). (F) Total number of different ILC subsets in the ear of mice treated with 
vehicle control (VC, n=6) or MC903 (n=15). (G) Schematic showing the experimental design 
of MC903 treatment combined within photoconversion of the inflamed ear. Data are pooled 
from a minimum of 2 independent experiments.  Each data point represents cells isolated 
from 1 ear and 1 auLN. Bars on scatter plots represents the median, which is also shown 
numerically. Statistical significance was tested using an unpaired, non-parametric, Mann-
Whitney two tailed U test: *p≤0.05, **p≤0.01, ***p≤0.001. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S13. CCR6 is expressed by all ILC subsets in the ear and auLN.  
CCR6 expression by ILC isolated from skin, peripheral LNs and mLN were compared using 
flow cytometry. ILC were identified as CD45+IL-7Rα+Lin{B220, CD11b, CD11c, CD3, CD5, 
CD19, Ter119, Gr1, CD49b, F4/80, Fc𝜀𝜀RI}- cells with subsets identified based upon 
transcription factor expression. (A) Representative flow cytometry plots of CCR6 expression 
by ILC1s, ILC2s and ILC3s isolated from the ear, auLN and mLN. (B) Percentage of ILC1s, 
ILC2s and ILC3s expressing CCR6 within the ear (left) (n=12), auLN (middle) (n=12) and 
mLN (right) (n=8). Each data point represents cells isolated from 1 ear, 1 auLN and 1 whole 
mLN. Data are pooled from a minimum of 2 independent experiments. Values on flow 
cytometry plots represent percentages, bars on scatter plots represents the median.  
 
 
 
